Use of a comprehensive panel of biomarkers to predict response to a fluorouracil-oxaliplatin regimen in patients with metastatic colorectal cancer.

Identifiers
Identifiers
Date issued
2011Journal title
PHARMACOGENOMICS
Type of content
Artigo
